- Home
- CGEM vs WRN Comparison
CGEM vs WRN Comparison
Compare CGEM & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- WRN
- Stock Information
- Founded
- CGEM 2016
- WRN 2006
- Country
- CGEM United States
- WRN Canada
- Employees
- CGEM N/A
- WRN N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- WRN Metal Mining
- Sector
- CGEM Health Care
- WRN Basic Materials
- Exchange
- CGEM Nasdaq
- WRN Nasdaq
- Market Cap
- CGEM 437.2M
- WRN 435.6M
- IPO Year
- CGEM 2021
- WRN N/A
- Fundamental
- Price
- CGEM $8.49
- WRN $2.08
- Analyst Decision
- CGEM Strong Buy
- WRN Strong Buy
- Analyst Count
- CGEM 7
- WRN 2
- Target Price
- CGEM $26.00
- WRN $4.13
- AVG Volume (30 Days)
- CGEM 1.5M
- WRN 1.5M
- Earning Date
- CGEM 11-07-2025
- WRN 11-05-2025
- Dividend Yield
- CGEM N/A
- WRN N/A
- EPS Growth
- CGEM N/A
- WRN N/A
- EPS
- CGEM N/A
- WRN N/A
- Revenue
- CGEM N/A
- WRN N/A
- Revenue This Year
- CGEM N/A
- WRN N/A
- Revenue Next Year
- CGEM N/A
- WRN N/A
- P/E Ratio
- CGEM N/A
- WRN N/A
- Revenue Growth
- CGEM N/A
- WRN N/A
- 52 Week Low
- CGEM $5.68
- WRN $0.90
- 52 Week High
- CGEM $17.50
- WRN $2.56
- Technical
- Relative Strength Index (RSI)
- CGEM 62.54
- WRN 51.43
- Support Level
- CGEM $7.69
- WRN $2.00
- Resistance Level
- CGEM $8.69
- WRN $2.19
- Average True Range (ATR)
- CGEM 0.65
- WRN 0.15
- MACD
- CGEM 0.06
- WRN -0.05
- Stochastic Oscillator
- CGEM 72.76
- WRN 15.79
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About WRN Western Copper and Gold Corporation
Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).